Jean-Pierre Hermet is Chairman of the Board of Directors for InGen BioSciences. Before that, he was Chairman of the Board for the group from 2008 to 2010.
Jean-Pierre started his career in pharmacy (Schering-Plough) and was then quickly appointed CEO at Wyeth Healthcare for France. Next he became Marketing President and then European President of a young American pharmaceutical company listed on the Amex stock exchange (Bentley Pharmaceuticals).
On his return to France, he created several biotechnology companies: Peptide Immune Ligands then Hybrigenics; he next founded Hemosystem, focused on developing and marketing rapid detection of bacteria in blood; he raised €8m through Risk Capital and lodged 26 patents.